Literature DB >> 33343664

Corrigendum to "Seroprevalence of Human Betaretrovirus Surface Protein Antibodies in Patients with Breast Cancer and Liver Disease".

Guangzhi Zhang1,2, Kiandokht Bashiri1, Mark Kneteman1, Kevan Cave1, Youngkee Hong1, John R Mackey3, Harvey J Alter4, Andrew L Mason1,5.   

Abstract

[This corrects the article DOI: 10.1155/2020/8958192.].
Copyright © 2020 Guangzhi Zhang et al.

Entities:  

Year:  2020        PMID: 33343664      PMCID: PMC7732377          DOI: 10.1155/2020/7406146

Source DB:  PubMed          Journal:  J Oncol        ISSN: 1687-8450            Impact factor:   4.375


In the article titled “Seroprevalence of Human Betaretrovirus Surface Protein Antibodies in Patients with Breast Cancer and Liver Disease” [1], a sentence in Section 2.2 was incorrect. The sentence “A serum panel of breast cancer patients (n = 98) and age/sex-matched controls (n = 102) was obtained from the Alberta Tomorrow Project, a longitudinal study tracking 55,000 adults in Alberta” should be corrected to “A serum panel of breast cancer patients (n = 98) and age/sex-matched controls (n = 102) was obtained from the breast cancer outpatient clinic Cross Cancer Institute.” The authors also wish to acknowledge an additional funding body. The modified Acknowledgments section is as follows.
  1 in total

1.  Seroprevalence of Human Betaretrovirus Surface Protein Antibodies in Patients with Breast Cancer and Liver Disease.

Authors:  Guangzhi Zhang; Kiandokht Bashiri; Mark Kneteman; Kevan Cave; Youngkee Hong; John R Mackey; Harvey J Alter; Andrew L Mason
Journal:  J Oncol       Date:  2020-01-27       Impact factor: 4.375

  1 in total
  1 in total

Review 1.  Mouse Mammary Tumour Virus (MMTV) in Human Breast Cancer-The Value of Bradford Hill Criteria.

Authors:  James S Lawson; Wendy K Glenn
Journal:  Viruses       Date:  2022-03-30       Impact factor: 5.818

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.